Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

CRH

CRH to Acquire Arcosa for $8.5 Billion

CRH said June 22 it has agreed to buy Arcosa in an all-cash deal valued at about $8.5 billion, or $150 a share. The offer represents a 25% premium to Arcosa’s 60-day trading volume-weighted average price as of June 18.

The transaction is priced at 11.5 times Arcosa’s 2026 adjusted EBITDA, including an estimated $175 million in annual run-rate cost synergies by year three. CRH said the deal should be accretive to earnings, margin and cash flow within the first 12 months after closing.

Arcosa brings 35 million tons of annual aggregates shipments from its construction products business, along with 109 quarries and yards, nine asphalt plants and 19 terminals. That lifts CRH’s combined annualized aggregates production to more than 265 million tons.

Arcosa’s infrastructure footprint also includes a top-three position in engineered structures, with exposure to grid modernization, electrification and data center construction. CRH said the target serves 13 of the 50 largest U.S. metro areas, including markets in Texas, New Jersey, Arizona, Florida and Tennessee.

The companies’ boards have approved the deal, which is expected to close in the first quarter of 2027. CRH said it plans to fund the acquisition with available cash and committed debt financing.

CRH said the combined balance sheet would show pro forma 2026 net debt to adjusted EBITDA of 2.4 times. The market has reacted to these announcements by moving the company's shares -0.85% to a price of $110.29. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS